We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LPCN market cap is 24.17M. The company's latest EPS is USD -3.0576 and P/E is -1.48.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | -2.91M | 7.62M | 90k | 0 |
| Operating Income | -7.04M | -2.59M | 3.22M | -3.29M | -2.63M |
| Net Income | -6.65M | -2.28M | 3.51M | -3.07M | -2.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 165k | 0 | 16.14M | 500k | -2.85M |
| Operating Income | -12.9M | -18M | 3.15M | -12.12M | -17.93M |
| Net Income | -13.01M | -20.97M | -634k | -10.76M | -16.35M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 24.75M | 23M | 25.45M | 23.03M | 20.7M |
| Total Liabilities | 2.27M | 2.63M | 1.49M | 1.82M | 1.58M |
| Total Equity | 22.48M | 20.37M | 23.96M | 21.21M | 19.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.66M | 25.35M | 52.48M | 37.54M | 23M |
| Total Liabilities | 13.37M | 10.01M | 6.91M | 1.91M | 2.63M |
| Total Equity | 6.29M | 15.34M | 45.57M | 35.64M | 20.37M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.84M | -11.87M | 2.41M | -90k | -2.92M |
| Investing | 10.36M | 13.09M | -4.09M | 662k | 1.69M |
| Financing | 410k | 405k | -8k | 209k | 209k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.67M | -15.3M | -4.41M | -11.97M | -11.87M |
| Investing | 3M | 3.89M | -43.78M | 14.29M | 13.09M |
| Financing | 10.32M | 20.9M | 26.93M | -2.13M | 405k |
| Market Cap | 24.17M |
| Price to Earnings Ratio | -1.48 |
| Price to Sales Ratio | -8.48 |
| Price to Cash Ratio | 5.07 |
| Price to Book Ratio | 1.19 |
| Dividend Yield | - |
| Shares Outstanding | 5.35M |
| Average Volume (1 week) | 41.02k |
| Average Volume (1 Month) | 31.65k |
| 52 Week Change | 16.80% |
| 52 Week High | 11.79 |
| 52 Week Low | 3.20 |
| Spread (Intraday) | 0.65 (13.27%) |
| Company Name | Lipocine Inc |
| Address |
919 north market street wilmington, delaware 19801 |
| Website | https://www.lipocine.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
